Mostrar el registro sencillo del ítem

Discovering Drugs to Treat Coronavirus Disease 2019 (COVID-19)

dc.contributor.authorDong, L, et al. Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.
dc.date.accessioned2020-03-20T18:43:58Z
dc.date.available2020-03-20T18:43:58Z
dc.identifier.urihttps://www.jstage.jst.go.jp/article/ddt/14/1/14_2020.01012/_articleen_US
dc.identifier.urihttps://hdl.handle.net/20.500.12663/498
dc.description.abstractThe SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far. This article summarizes agents with potential efficacy against SARS-CoV-2.en_US
dc.titleDiscovering Drugs to Treat Coronavirus Disease 2019 (COVID-19)en_US
eihealth.countryOthersen_US
eihealth.categoryCandidate therapeutics RDen_US
eihealth.typePublished Articleen_US
eihealth.maincategorySave Lives / Salvar Vidasen_US


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem